Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTH1R | Q03431 | 6/20 | 0.43 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL849378 | 0.85 | PTH1R (0.49) | PTH1RCALCRLKDM4EALDH1A1HPGD | |
| SCHEMBL13555121 | 0.84 | PTH1R (0.46) | PTH1RCALCRLKDM4EALDH1A1HPGD | |
| SCHEMBL850398 | 0.81 | PTH1R (0.41) | PTH1RCALCRL | |
| SCHEMBL13385961 | 0.71 | PTH1R (0.52) | PTH1RCALCRL | |
| SCHEMBL849883 | 0.71 | PTH1R (0.52) | PTH1RCALCRLKDM4EALDH1A1HPGD | |
| SCHEMBL846939 | 0.70 | MEN1 (0.54) | PTH1R | |
| SCHEMBL13552099 | 0.69 | PTH1R (0.48) | PTH1RCALCRL | |
| SCHEMBL848776 | 0.69 | MEN1 (0.51) | PTH1RKDM4EALDH1A1HPGD | |
| SCHEMBL847703 | 0.69 | NEK2 (0.52) | PTH1RALDH1A1HPGD | |
| SCHEMBL849399 | 0.69 | PTH1R (0.57) | PTH1RCALCRL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9169254-B2 | Spiroimidazolone derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2015-10-27 | — | — | US | disclosed |
| US-9169254-B2 | Spiroimidazolone derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2015-10-27 | — | — | US | disclosed |
| US-20120270838-A1 | SPIROIMIDAZOLONE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2012-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120270838-A1 | SPIROIMIDAZOLONE DERIVATIVE | WNK3, REN, SGK3 | PTH1R 1869/4885CALCRL 1957/4885KDM4E 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.